• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Guardant Health, Inc. - Common Stock (NQ:GH)

    95.56 +0.64 (+0.67%)
    Streaming Delayed Price Updated: 3:03 PM EDT, May 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 684,372
    Open 95.96
    Bid (Size) 95.46 (100)
    Ask (Size) 95.63 (100)
    Prev. Close 94.92
    Today's Range 93.29 - 97.48
    52wk Range 36.36 - 120.74
    Shares Outstanding 101,298,669
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Why Guardant Health (GH) Stock Is Down Today
    What Happened? Shares of diagnostics company Guardant Health (NASDAQ:GH) fell 4.1% in the afternoon session after Co-CEO AmirAli Talasaz sold 50,000 shares o... 
    Via StockStory
    News headline image
    The Top 5 Analyst Questions From Guardant Health’s Q1 Earnings Call
    Guardant Health delivered a strong start to 2026, outperforming Wall Street’s revenue expectations in Q1 as robust demand across its core oncology, biopharma... 
    Via StockStory
    Topics Earnings

    Performance

    YTD
    -6.1%
    -6.1%
    1 Month
    +5.8%
    +5.8%
    3 Month
    -10.8%
    -10.8%
    6 Month
    -1.0%
    -1.0%
    1 Year
    +137.5%
    +137.5%

    More News

    Read More
    News headline image
    Guardant Health (GH) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Guardant Health (NASDAQ:GH) Smashes Q1 Estimates, Raises Full-Year Guidance on Soaring Screening Revenue ↗
    Via Chartmill
    News headline image
    GH Q1 Deep Dive: Shield Volume Acceleration and Oncology Portfolio Expansion Fuel Growth
    Via StockStory
    News headline image
    Guardant Health (NASDAQ:GH) Delivers Impressive Q1 CY2026, Stock Soars
    Via StockStory
    News headline image
    Guardant Health Reports First Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health Earnings: What To Look For From GH
    Via StockStory
    News headline image
    Guardant Health Receives FDA Approval for Guardant360® CDx as a Companion Diagnostic for Arvinas and Pfizer’s VEPPANU (vepdegestrant) for Patients with ER+/HER2- Advanced Breast Cancer with ESR1 Mutations
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health to Participate in Upcoming Investor Conferences
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Government Stocks
    News headline image
    1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
    Via StockStory
    News headline image
    Why Is Guardant Health (GH) Stock Soaring Today
    Via StockStory
    Topics Government Stocks
    News headline image
    Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Why Guardant Health (GH) Stock Is Falling Today
    Via StockStory
    Topics Artificial Intelligence Economy Government
    News headline image
    3 Growth Stocks We Think Twice About
    Via StockStory
    News headline image
    Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics
    Via MarketMinute
    Topics Supply Chain
    News headline image
    3 Reasons to Avoid GH and 1 Stock to Buy Instead
    Via StockStory
    Topics Supply Chain
    News headline image
    Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Battery Storage Stock Up 50% in a Year Draws New $110M Investment. Here's What You Should Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings ↗
    Via The Motley Fool
    Topics Regulatory Compliance

    Frequently Asked Questions

    Is Guardant Health, Inc. - Common Stock publicly traded?
    Yes, Guardant Health, Inc. - Common Stock is publicly traded.
    What exchange does Guardant Health, Inc. - Common Stock trade on?
    Guardant Health, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Guardant Health, Inc. - Common Stock?
    The ticker symbol for Guardant Health, Inc. - Common Stock is GH on the Nasdaq Stock Market
    What is the current price of Guardant Health, Inc. - Common Stock?
    The current price of Guardant Health, Inc. - Common Stock is 95.56
    When was Guardant Health, Inc. - Common Stock last traded?
    The last trade of Guardant Health, Inc. - Common Stock was at 05/18/26 03:03 PM ET
    What is the market capitalization of Guardant Health, Inc. - Common Stock?
    The market capitalization of Guardant Health, Inc. - Common Stock is 9.68B
    How many shares of Guardant Health, Inc. - Common Stock are outstanding?
    Guardant Health, Inc. - Common Stock has 10B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.